Showcasing LRRK2 Inhibitors as Treatment for Parkinson’s Disease

Time: 12:00 pm


  • Exploring the role of LRRK2 in the pathophysiology of Parkinson’s disease
  • Uncovering case studies which showcase the benefit of therapeutic approaches to inhibit LRRK2
  • Revealing how new small molecule inhibitors of LRRK2 can be used to treat Parkinson’s disease